(Q33743937)

English

Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

streptococcal pharyngitis

1 reference

based on heuristic

inferred from title

author name string

J C Christenson

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

E Swenson

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

W M Gooch

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J N Herrod

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 June 1991

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1127-1130

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

Importance of patient compliance in effective antimicrobial therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

In vitro activity of BMY-28100 against common isolates from pediatric infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

In vitro activity of BMY-28100, a new oral cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

BMY 28100, a new oral cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

Phase I study of multiple-dose cefprozil and comparison with cefaclor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284298

21 June 2018

Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929253

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefaclor in the treatment of susceptible infections in infants and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929253

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SIGNIFICANCE OF THE STAPHYLOCOCCUS AUREUS CARRIER STATE IN THE TREATMENT OF DISEASE DUE TO GROUP A STREPTOCOCCI

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929253

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.35.6.1127

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33743937&oldid=1977928589"